U.S. FDA Approves Aptar’s Proprietary Activ-Film™ Technology for use with Rechargeable Implantable Neurostimulator
Sophisticated implantable medical device for urinary and bowel dysfunction leverages [...]
Aptar CSP Technologies’ Activ-Film™ Technology Protects New At-Home Prescription and OTC COVID-19 Tests
Auburn, AL, April 28, 2021 – Aptar CSP Technologies, a [...]
Aptar CSP Technologies Earns ISO Quality Certifications for Medical Device Production
Certification affirms the company’s quality management systems meets ISO requirements [...]
Aptar’s Activ-Film™ Technology Selected to Protect New SARS Rapid Antigen Test for COVID-19 Diagnosis
Crystal Lake, Illinois, February 15, 2021 - AptarGroup, Inc. (NYSE: [...]
Aptar CSP Technologies Increases Capacity for Active Packaging Solutions that Protect Diagnostic Test Kits
Patented 3-Phase Activ-Polymer™ platform technology protects electrochemical, lateral flow, and [...]
Probiotics Packaging Feature Article Published in Nutritional Outlook
Two of the most critical aspects of probiotics manufacturing and [...]
Aptar Submits Application for Emergency Use Authorization to the German Regulatory Agency BfArM for ActivShield™ FFP2 Decontamination System
Crystal Lake, Illinois, May 8, 2020 - AptarGroup, Inc. (NYSE: [...]
Aptar Requests U.S. FDA Emergency Use Authorization for ActivShield™ N95 Filtering Facepiece Respirator Decontamination System
Crystal Lake, Illinois, April 3, 2020 - AptarGroup, Inc. (NYSE: [...]
Aptar CSP Launches Fully-Integrated Active Packaging Solution Combining Moisture Adsorption and Oxygen Scavenging Properties
New oxygen scavenging and moisture adsorption solution added to Aptar [...]
